Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New MMP-13 inhibitors and their use reported by Pfizer scientists

Sep. 13, 2004

New PDE7 inhibitors claimed by Almirall Prodesfarma researchers

Sep. 13, 2004

s-CD23 production inhibitors newly developed at GSK

Sep. 13, 2004

Incyte patent covers novel antitumor agents targeting JNK signaling pathways

Sep. 13, 2004

New factor Xa/factor VIIa inhibitors covered by Merck KGaA patent

Sep. 13, 2004

Novel HIV integrase inhibitors prepared and tested at Pfizer

Sep. 13, 2004

Two series of glucokinase activators presented by Lilly scientists

Sep. 13, 2004

New peptides targeting tumor cells and their use claimed by Attenuon

Sep. 10, 2004

New c-Kit inhibitors under study at OSI

Sep. 10, 2004

Novel CHK1 kinase inhibitors identified by Pfizer team

Sep. 10, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...